Anixa Biosciences, Inc.
ANIX
$2.77
-$0.01-0.18%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.82% | -19.35% | 19.07% | 12.37% | -10.44% |
| Total Depreciation and Amortization | 11.11% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.32% | 1.71% | -27.94% | 47.03% | -20.53% |
| Change in Net Operating Assets | -247.07% | 828.05% | -158.57% | 127.83% | -151.70% |
| Cash from Operations | -107.97% | 16.94% | -0.53% | 48.24% | -213.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.77% | 178.51% | -135.57% | -13.36% | 211.76% |
| Cash from Investing | 87.77% | 178.51% | -135.57% | -13.36% | 211.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.93% | -83.82% | 51,200.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8,927.78% | 114.63% | -823.53% | 200.00% | -112.23% |
| Cash from Financing | 381.43% | -81.86% | 10,616.67% | 205.88% | -116.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 220.72% | 39.52% | -148.42% | 493.12% | -573.91% |